The Baltic States: A Growing Clinical Research Market The Baltic States approve around 80 new clinical trial applications per country each year, falling mainly within the therapeutic areas of oncology, neurology/psychiatry, and endocrinology. States legislation is harmonized and the regulatory process is similar to other EU countries. The timelines are also attractive—the approval process takes approximately 60 days. Donatas Grina, Indre Tutlyte, Audrius Sveikata look at these and other factors that make the region an attractive location for clinical trials. Read more
Dealmaking: How to Stay Ahead of the Curve The record-breaking level of dealmaking activity in the pharmaceutical sector reveals profound strategic shifts occurring in the industry that will change the transactions field for companies out across the next five to ten years. Amid this surge in M&A activity, Michael Swanick asks: What are the crucial considerations pharma executives should weigh before sitting down at the deals table?... Read more
Global Access to TB Drugs Reaches Milestone TB advocacy campaigner Treatment Action Group (TAG) has reached a milestone in improving access to TB treatments. Sanofi’s reduction of the 340B federal discount program price of Priftin (rifapentine) from $73 to $51 and further in January to $32 per box is a historical win for the TB community, according Erica Lessem, TB/HIV Project Assistant Director... Read more
Pharm Exec Global: Big Data Special In the latest issue of the Pharm Exec Global Digest: Unlocking the true value of Big Data; Data privacy and the health sciences; Successfully integrating Big Data analytics with a company’s existing systems; In-silico modeling and real-word outcomes; and more .... Read more
